Respiratory viral infections prime accelerated lung cancer growth
Wei Qian(Carter Center), Jie Sun(Carter Center), In Su Cheon(Carter Center), Qing Yu(Fujian Medical University), Bimal N. Desai(University of Virginia), Harish Narasimhan(Carter Center), Y. J. Park(Carter Center), Haibo Zhang(St. Michael's Hospital), Chaofan Li(Heilongjiang University of Chinese Medicine), Peter Chen(Cedars-Sinai Medical Center), Xiangyu Ye(University of Pittsburgh), Anny Xiaobo Zhou(University of Virginia), Eric V. Yeatts(Carter Center), Sijie Hao(University of Virginia), Andrew Barros(University of Virginia), Nicole A. Kirk(University of Virginia), Samuel P. Young(University of Virginia), Valeria Molinary(University of Virginia), Jinyi Tang(Carter Center), Gislane Almeida-Santos(Carter Center), Xiaoqin Wei(Carter Center), Wei Chen(Children's Hospital of Pittsburgh), Li Li(University of Virginia), Ying Li(Mayo Clinic in Florida), Kwon-Sik Park(University of Virginia), Jeffrey M. Sturek(Carter Center)
Cited by 4
Related Papers
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|548
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Correlation of serial blood lactate levels to organ failure and mortality after trauma
|The American Journal of Emergency Medicine|1995|314
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs
|American Journal of Respiratory and Critical Care Medicine|2020|165